Derma Sciences, Inc (DSCI)

[surf1944]

7:16AM Derma Sciences sees 2013 revenue of approx $79.7 mln, Capital IQ consensus $85 mln; co sees 2014 revenue of approx $92 mln, Capital IQ consensus $94.1 mln (DSCI) 12.36 : Co announced that total revenue for the full year ended December 31, 2013 is expected to be $79.7 million, up 7.7% compared with 2012. Advanced wound care (AWC) revenue for the fourth quarter of 2013 is expected to be $9.4 million, up 22.5% compared with the fourth quarter of 2012, and full year 2013 AWC revenue is expected to be $33.9 million, up 36.6% compared with 2012. Derma Sciences expects to report 2013 full financial results on March 14, 2014.

The Company expects 2014 total revenue to increase approximately 15.5% to $92 million, driven primarily by the continued organic AWC revenue growth for the year of 30% to 40%.